Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2013-09-30
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that treatment of psoriasis with UVB delivered via 308 nm excimer laser will decrease the levels of serum inflammatory markers. The investigators hypothesize that treatment will decrease plaque erythema and will result in minimal hyperpigmentation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis
NCT02294981
308nm Excimer Laser for Treatment of Fingernail Psoriasis
NCT02168933
Excimer Light in Psoriasis
NCT05283876
Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and Soles
NCT02181790
Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis
NCT00470392
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Excimer laser
Excimer laser treatment
Excimer laser treatment
Excimer laser irradiation twice a week for up to 20 treatments.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Excimer laser treatment
Excimer laser irradiation twice a week for up to 20 treatments.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female with diagnosis of psoriasis
* Psoriasis involvement of 5-15% BSA
* Has been off systemic psoriasis therapies (e.g. retinoids, methotrexate, biologic agents, etc) for at least 4 weeks
* Has been off topical therapies (e.g. calcipotriene, topical steroids) for at least 2 weeks
* Fitzpatrick Skin Types I-VI
Exclusion Criteria
* Any suspicion that the psoriasis is of the photosensitive variant.
* Any medical condition that could be aggravated or may cause extreme discomfort during the study period.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Photomedex
UNKNOWN
University Hospitals Cleveland Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Margaret Bobonich, NP
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Margaret Bobonich, NP
Role: PRINCIPAL_INVESTIGATOR
University Hospitals Cleveland Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals Cleveland Medical Center (Concord Site)
Concord, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-13-33
Identifier Type: OTHER
Identifier Source: secondary_id
06-13-33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.